ENOUGH are proud to announce the raising of €40 million in growth funding co-led by World Fund and CPT in order to scale up production. Other previous investors, including AXA IM Alts through the Axa Impact Fund, HAL Investments through 280ppm, Onassis Group through Olympic Investments Inc, Tailored Solutions and Scottish Enterprise also followed on. The new growth funding brings the total capital raised by ENOUGH to over €95 million.

With this funding boost, we will be able to scale up capacity at our factory in the Netherlands to serve our growing customer demand for ABUNDA® mycoprotein and to internally grow our teams across our offices in Glasgow, London and Sas van Gent. These efforts will help us to achieve our ambitious growth goal of producing one million tonnes of ABUNDA® cumulatively within 10 years, the equivalent of replacing 5 million cows or over 1 billion chickens, to feed a growing global population and tackle the unsustainable impact of traditional protein farming. 

We would like to express our sincerest appreciation to all our investors who have supported us. They are a vital part of our success, and we look forward to continued growth together.

Read the full press announcement here.